EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches

D’Angelo, V.; Iannotta, A.; Ramaglia, M.; Lombardi, A.; Zarone, M. R.; Desiderio, V.; Affinita, M. C.; Pecoraro, G.; Di Martino, M.; Indolfi, P.; Casale, F.; Caraglia, M.

doi:10.1186/s13046-015-0191-0

Journal of Experimental & Clinical Cancer Research

Article metrics
Last updated: Fri, 19 Apr 2024 17:06:03 Z

EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches

Access & Citations

3220

Article Accesses
19

Web of Science
19

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1756-9966

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com